Hyper Immunoglobulin E (IgE); an immune deficiency (Job Syndrome)
Abstract
Hyper-IgE Syndrome (HIES), also known as Job Syndrome; is a rare genetic disorder that affects the immune system and can lead to various health complications. The text mentions cornerstone of HIES therapy is proper skin care, infection prevention, and aggressive infection treatment. Treatments for HIES can include antibiotics that target S. aureus, typically used to reduce the incidence of pneumonia and the risk of lung damage. Skincare routines can involve bleach baths or chlorhexidine washes, oral anti-staphylococcal prophylactic antibiotics, and other treatments to avoid abscesses. Antifungal prophylaxis may be beneficial for HIES patients who have chronic Candida infections. Defects in antibody synthesis can vary, making it difficult to provide general recommendations for immune globulin replacement in HIES.
Downloads
References
Hafsi, W.; Yarrarapu, S. N. S. Job syndrome. StatPearls [Internet] 2021.
DOI: https://doi.org/10.1073/pnas.2020100118Hafsi, W.; Badri, T. Job syndrome (hyperimmunoglobulin E). 2018.
Grimbacher, B; Holland, S. M. Gallin, J. I. Greenberg, F Hill,
Available from: https://europepmc.org/article/nbk/nbk525947
Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. syndrome with recurrent infections—an autosomal dominant multisystem disorder. New England Journal of Medicine 1999; 340 (9), 692.
DOI: https://doi.org/10.1056/NEJM199903043400904
Santana, P, Medeiros, A. K. Barbisan, C. Gomes, A. Marchior E. Hyperimmunoglobulin E syndrome (Job syndrome): chest CT findings. Jornal Brasileiro de Pneumologia 2018; 44, 335.
DOI: https://doi.org/10.1590/S1806-37562017000000175
Kumanovics A,, Gilbert H, Cessna MH. Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation. J Clin Immunol 2010.
DOI: https://doi.org/10.1007/s10875-010-9452-z
Sowerwine, K, Holland, S, Freeman, A. Hyper‐IgE syndrome update. Ann N Y Acad 2012; 1250 (1) 25.
DOI: https://doi.org/10.1111/j.1749-6632.2011.06387.x
Freeman AF, Avila EM, Shaw PA, Davis J, Hsu AP, Welch P, et al. Coronary artery abnormalities in Hyper-IgE syndrome. J Clin Immunol. 2011 Jun;31:338-45.
DOI: https://doi.org/10.1007/s10875-011-9515-9
Sheerin KA, Buckley RH. Antibody responses to protein, polysaccharide, and ΦX174 antigens in the hyperimmunoglobulinemia E (hyper-IgE) syndrome. J Allergy Clin Immunol. 1991; 87(4):803-11.
DOI: https://doi.org/10.1016/0091-6749(91)90126-9
Kimata H. High-dose intravenous γ-globulin treatment for hyperimmunoglobulinemia E syndrome. J Allergy Clin Immun. 1995; 95(3):771-4.
DOI: https://doi.org/10.1016/S0091-6749(95)70185-0
Wakim M, Alazard M, Yajima A, Speights D, Saxon A, Stiehm ER. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. . Ann Allergy Asthma Immunol. 1998; 81(2):153-8.
DOI: https://doi.org/10.1016/S1081-1206(10)62802-5
Bilora F, Petrobelli F, Boccioletti V, Pomerri F. Moderate-dose intravenous immunoglobulin treatment of Job's syndrome. Case report. Minerva Med. 2000; 91(5-6):113-66
Copyright (c) 2023 Journal of Shifa Tameer-e-Millat University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Shifa Tameer-e-Millat University (JSTMU) is the owner of all copyright to any work published in the journal. Any material printed in JSTMU may not be reproduced without the permission of the editors or publisher. The Journal accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing and/or decision in this journal. The Editorial Board makes every effort to ensure the accuracy and authenticity of material printed in the journal. However, conclusions and statements expressed are views of the authors and do not necessarily reflect the opinions of the Editorial Board or JSTMU.
Content of this journal is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.